Industry
Featured experience
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Charles River Laboratories cooperation agreement with Elliott
We are advising Charles River on the agreement
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
RayzeBio $358 million IPO
The stock is listed on the Nasdaq Global Market
Natera $250 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
PracticeTek merger with Integrated Practice Solutions and related financing
We advised Lightyear Capital and PracticeTek on the transaction to form a leading U.S. retail healthcare solutions provider
Walgreens Boots Alliance registered variable prepaid forward transactions
The transactions cover up to 10,500,000 shares of AmerisourceBergen stock
Mallinckrodt prepackaged chapter 11 filing and restructuring support agreement
We are advising an ad hoc group of first-lien noteholders
Abcam $5.7 billion acquisition by Danaher
We advised financial advisers to Abcam on the transaction
TRYT ¥55.2 billion IPO
The shares are listed on the Tokyo Stock Exchange
Johnson & Johnson splits off Kenvue
This is the largest split-off transaction ever done
AN2 Therapeutics $70 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
RAPT Therapeutics $150 million at-the-market offering
The shares are listed on the Nasdaq Global Market